Investors in Health

QantX is dedicated to fostering high-impact innovations within the South & West regions, ensuring they contribute to local economic growth by creating high-value jobs and increasing economic output. The firm supports early-stage founders by maximizing local capital, providing deep commercial expertise, and leveraging international networks. QantX engages in individual and collaborative investments, emphasizing both founder and investor exits to drive entrepreneurial success. The executive team brings substantial experience and leadership to guide startups through strategic growth phases, aiming to sustain and enhance the regional innovation ecosystem.

Silicon Roundabout Ventures is a community-driven venture capital firm specializing in backing Deep Tech and Big Data startups at the pre-seed and seed stages. Leveraging a robust community of 15,000 founders and engineers, they support startups through live pitching competitions that have showcased winners now collectively valued at over £6 billion. Silicon Roundabout Ventures aims to identify and nurture innovative startups in technology, providing strategic support and access to a vast network to accelerate their growth and success in the global market.

Selvedge Venture is a venture capital advisory and management firm headquartered in London, UK. Specializing in providing strategic guidance and management services, Selvedge Venture supports early-stage and growth-stage companies in navigating the complex landscape of venture capital. With a focus on fostering innovation and sustainable growth, Selvedge Venture aims to empower entrepreneurs and startups to achieve their full potential in the competitive global market.

Sustainable Future Ventures (SFV) is a venture capital firm dedicated to investing in technology companies that are leading the way towards a more sustainable built environment. Leveraging deep relationships within the real estate sector, SFV identifies and supports innovative technologies that address environmental, economic, and social sustainability challenges across the real asset value chain. SFV's investment focus spans from technologies that influence how new assets are built and the materials used, to transforming transactions and operational practices within the built environment. They operate globally, investing from late seed to Series B stages, and are supported by PATRIZIA, enhancing their ability to drive impactful change through strategic investments in transformative technologies.

Ponderosa Ventures is committed to driving radical change in the food, agriculture, and ocean sectors to meet climate, biodiversity, water, justice, and human health goals. We invest $100-750k in pre-seed and seed-stage companies globally, with a particular focus on the US and Europe. Our streamlined investment process aims to provide quick decisions, typically reaching a yes or no within an average of 18 days (updated live). This efficiency allows entrepreneurs to focus on building their companies while we support transformative innovations in these critical sectors.

Turquoise International is a specialized merchant bank focusing on the Energy, Environment, and Efficiency sectors. The firm provides advisory and financial services tailored to companies and projects that contribute to sustainable practices and efficient resource management. Turquoise International leverages its industry expertise to facilitate transactions, investments, and strategic initiatives that promote environmental sustainability and energy efficiency. Through its comprehensive approach, Turquoise International plays a pivotal role in supporting businesses and projects that aim to make a positive impact on the environment while fostering economic growth and innovation in these sectors.

Eurovestech PLC is an AIM-listed pan-European development capital fund that specializes in investing in high-technology enterprises. The firm focuses on identifying and supporting innovative companies across Europe with high growth potential, particularly in sectors such as technology and digital media. Eurovestech provides strategic development capital to help these enterprises accelerate their growth, expand their market presence, and achieve their strategic objectives. As a publicly listed company on the AIM market, Eurovestech offers investors the opportunity to participate in the growth of promising high-tech businesses through transparent and regulated investment vehicles. The firm's investment strategy emphasizes active management and value creation, aiming to maximize shareholder value while supporting the development of transformative technologies and businesses.

Exceptional Ventures, we are a London-based venture capital firm dedicated to investing in high-impact startups that contribute to improving the world we live in. Our mission is clear: we aim to help people live healthier, happier, and longer lives while promoting a sustainable planetary ecosystem. Through our debut fund, EV Fund 1, which targets £20 million in size, we are actively building a portfolio of 40 early-stage startups over the next three years. Our focus areas include HealthTech, FoodTech, and Financial Health, primarily within the UK/EU region while opportunistically exploring opportunities globally. Our founders, Matt Cooper and Paolo Pio, bring a wealth of experience to Exceptional Ventures. Matt's background includes co-founding Capital One Bank in the US, Tandem Bank in the UK, and chairing Octopus Group for over two decades. Paolo, formerly a Silicon Valley Software Engineer and Tech Executive, transitioned into venture capital as MD Europe at Joyance Partners, a prominent US HealthTech VC fund. With a combined portfolio of over 200 invested startups, we leverage our deep industry knowledge and extensive network to support entrepreneurs and drive positive societal impact through strategic investments.

Leafy Tunnel is a Venture Capital firm dedicated to investing in alternative medicine, focusing on the transformative potential of medicinal cannabis and psychedelics. Through direct investments, we aim to foster the growth of pioneering companies leading research, development, and commercialization in these sectors. In controlled therapeutic settings, these modalities offer promise in unraveling the mysteries of the mind, revealing pathways to self-discovery and emotional healing. Alternative medicine, particularly in psychedelic and cannabis therapies, challenges traditional healing approaches, merging ancient wisdom with modern science to explore the limitless potential of human consciousness. This convergence forms a new paradigm where art, music, and culture blend with therapeutic practices, enhancing self-exploration and emotional liberation. At Leafy Tunnel, we leverage our extensive network, expertise, and resources to collaborate with entrepreneurs and startups that share our vision for the future of alternative medicine. Our investment approach emphasizes rigorous analysis, honest feedback, and a commitment to ethical and sustainable practices.

LifeArc is an independent life science medical research charity dedicated to improving positive patient outcomes globally. As a pioneering organization, LifeArc focuses on translating cutting-edge biomedical research into tangible benefits for patients and society. Their mission spans across the entire medical innovation pipeline, from early-stage discovery to development and commercialization. LifeArc collaborates with academic institutions, research organizations, and industry partners to accelerate the translation of scientific discoveries into new treatments and therapies. Through strategic funding, expertise, and partnerships, LifeArc supports innovative projects that address unmet medical needs and advance medical science. Committed to making a significant impact on healthcare, LifeArc plays a crucial role in driving innovation, fostering collaboration, and ultimately, improving patient lives worldwide.

ODBA, we hold a firm conviction that founders with hands-on experience in launching, managing, and expanding businesses possess the keenest insight for investment. Our approach hinges on the understanding that the success of a venture is deeply intertwined with the caliber of its team. For us, a team's excellence reflects their collective passion, vision, dedication, and communication skills. People are at the heart of everything we do. We do not just invest in ventures, products, or ideas; we invest in the individuals who build them. As founders ourselves, we are committed to investing in people who resonate with our entrepreneurial spirit, wherever and however we find them.

Rosetta Capital Limited operates as a private equity and venture capital firm specializing in direct secondary investments. The firm focuses on acquiring direct stakes in private companies from existing shareholders, providing liquidity and growth capital to support these businesses. Rosetta Capital's investment strategy involves identifying attractive opportunities in established companies with strong growth potential and sustainable business models. By leveraging its expertise in direct secondary transactions, the firm aims to generate value and foster growth within its portfolio companies. Rosetta Capital plays a crucial role in the secondary market, facilitating transactions that enable shareholders to realize value while positioning portfolio companies for continued success and expansion.